SEERSeer, Inc.

$101M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+129.7% YoY

Gross Profit

$384,0002.6% margin

Operating Income

-$98M-667.6% margin

Net Income

-$93M-633.1% margin

EPS (Diluted)

$-1.42

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$71M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$488M

Total Liabilities

$41M

Stockholders' Equity

$447M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$6M	+129.7%
Gross Profit	$384,000	-$374,000	+202.7%
Operating Income	-$98M	-$72M	-36.7%
Net Income	-$93M	-$71M	-30.6%

SEER FY 2022 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena